Helen Torley - Insider Trading & Ownership

Location: C/O Onyx Pharmaceuticals, Inc., 249 East Grand Ave., South San Francisco, CA
Summary: The estimated net worth of Helen Torley is at least $56.7M dollars as of December 1, 2025. Helen Torley is the PRESIDENT AND CEO, Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $56M. Helen Torley is the Director of QUEST DIAGNOSTICS INC and owns shares of QUEST DIAGNOSTICS INC (DGX) stock worth about $769K.
Signature: /s/ James R. Oehler, Attorney-in-Fact
All Insider Reports: All Insider Reports

Email me when Helen Torley files a new Ownership 3,4,5 report.

Ownership of Helen Torley

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
HALO	HALOZYME THERAPEUTICS, INC.	PRESIDENT AND CEO, Director	$56M	-$24.5M	-30.4%	Nov 26, 2025
DGX	QUEST DIAGNOSTICS INC	Director	$769K			May 25, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.